Physician profile
Bryan Mccullough
NPI 1124284963
$5,429.41
in general payments reported to CMS, 2019-2025
9 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $817 · 2020: $38.94 · 2021: $2,454 · 2022: $1,329 · 2023: $63.61 · 2024: $316 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $790.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Legacy Ortho LLC | $3,859.30 | 2021-2025 | |
| Cdc Medical LLC | $732.00 | 2019 | |
| Depuy Synthes Sales INC. | $520.54 | 2024-2025 | Orthovisc, Monovisc |
| Ferring Pharmaceuticals INC. | $174.51 | 2019-2023 | Euflexxa |
| Smith+Nephew, INC. | $51.82 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Sanofi-Aventis U.S. LLC | $30.72 | 2019-2020 | |
| Bioventus LLC | $24.24 | 2024 | Durolane |
| Stryker Corporation | $20.73 | 2023 | Blueprint Patient Specific Instrumentation |
| Arthrex, INC. | $15.55 | 2023 | Arthrex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Mccullough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.